The company
AbbVie Inc.
ABBV · NYSE
ABBV stood above a rising 150-day average in 37 of the last 52 weekly readings, including each of the last 17 weeks. It is 20.4% above that average now. Pharmaceuticals: 31% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 17 in a row
- Industry in uptrend
- 31% -7 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $37.8M
- Officials’ trades on record
- 221
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 37 of 52 weeks.
Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars. Not yet read: institutions.
Congress and officials
221 disclosed lines: House 154, Senate 39, executive 28; 65 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Pete Sessions House: U.S. House ClerkTX17 | sold | $15k–$50k | 14 Sep 2026filed 18 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $50k–$100k | 31 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $50k–$100k | 23 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 23 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $50k–$100k | 16 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $100k–$250k | 18 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 18 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $50k–$100k | 15 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 11 May 2026filed 1 Jul 2026 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | soldjoint | $1k–$15k | 5 May 2026filed 3 Jun 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 28 Apr 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $100k–$250k | 27 Apr 2026filed 1 Jul 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Nicholas DonoghoeEVP, CHIEF BUS/STRAT OFFICER | sold | 32,710at $250.00 | 14 Aug 2026filed 18 Aug 2026 |
| David Ryan PurdueSVP, Controller | sold | 5,230at $233.56 | 4 Mar 2026filed 6 Mar 2026 |
| Perry C. SiatisEVP, GC AND SECRETARY | sold | 5,777at $233.51 | 2 Mar 2026filed 3 Mar 2026 |
| Perry C. SiatisEVP, GC AND SECRETARY | sold | 10,291at $234.66 | 2 Mar 2026filed 3 Mar 2026 |
| Perry C. SiatisEVP, GC AND SECRETARY | sold | 2,600at $235.26 | 2 Mar 2026filed 3 Mar 2026 |
| Perry C. SiatisEVP, GC AND SECRETARY | sold | 22,381at $230.00 | 25 Feb 2026filed 27 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Still reading this part; it fills in a moment.
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.